Categories Cancer

Two-year-old girl, diagnosed with a rare type of cancer, gets successfully treated in Chennai hospital

Two-year-old girl, diagnosed with a rare type of cancer, gets successfully treated in Chennai hospital CHENNAI: Doctors at the Gleneagles Global Health City in Chennai successfully treated a 2-year-old from Assam, who was detected with a lesion in her mouth last year in April.  According to a statement from the hospital, even though the lesion […]

Read More
Categories Cancer

Orion and Bayer expand development program for darolutamide in prostate cancer

Orion and Bayer expand development program for darolutamide in prostate cancer ORION CORPORATION PRESS RELEASE 8 FEBRUARY 2021 at 14.00 EET                       Orion and Bayer expand development program for darolutamide in prostate cancer Phase III study ARANOTE to be initiated in metastatic hormone-sensitive prostate cancer (mHSPC) assessing the novel androgen-receptor antagonist in combination with standard […]

Read More
Categories Cancer

Hologic taps Google Cloud for AI-driven cervical cancer screening collaboration

Hologic taps Google Cloud for AI-driven cervical cancer screening collaboration Hologic has tapped Google Cloud to help elevate its digital pathology platforms for diagnosing cervical cancer with new artificial intelligence and machine learning programs. The medtech’s Genius cytology system digitally stacks 2D images of a patient’s cells to provide additional visual depth to glass Pap […]

Read More
Categories Cancer

Mapping challenges India faces in fight against cancer

Mapping challenges India faces in fight against cancer Despite advancements in medical technology and health infrastructure, the cancer graph in India continues to climb calling for a need to relook and upscale the strategies for prevention and control of the disease. Cancer arises from the transformation of normal cells into tumour cells in a multistage […]

Read More
Categories Multiple Myeloma

Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the …

Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the … Corresponding Author Multiple Myeloma Program, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Correspondence: Dickran Kazandjian, M.D., Multiple Myeloma Program, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, […]

Read More
Categories Cancer

Racial Disparities in Palliative Care Use Found Among Patients with Ovarian and Cervical Cancer

Racial Disparities in Palliative Care Use Found Among Patients with Ovarian and Cervical Cancer According to a study published in Data in Brief, disparities in palliative care use exist among patients with metastatic gynecological cancers, suggesting there is unequal treatment among these patients according to race/ethnicity. If utilized correctly, the research team suggests these data […]

Read More
Categories Cancer

Adjuvant Radiotherapy Linked With Survival Benefit After Distal Cholangiocarcinoma Resection

Adjuvant Radiotherapy Linked With Survival Benefit After Distal Cholangiocarcinoma Resection Patients who underwent adjuvant radiotherapy (RT) after resection of distal cholangiocarcinoma (dCCA) experienced a survival benefit, even in those with margin-negative or node-negative resections, according to data published in Cancer. Because of this survival benefit association, the investigators suggest that adjuvant RT be considered routinely […]

Read More
Categories Multiple Myeloma

Global Biologic Market Size, Share, Value, and Competitive Landscape 2021

Global Biologic Market Size, Share, Value, and Competitive Landscape 2021 Global biologic market is expected to grow at a CAGR of 8.6% during forecasted period 2017-2023 and reach till $425 million by end of 2023. Biologics are the drugs prepare or obtain from the biological organism. They are composed of protein, sugars or nucleic acids. […]

Read More
Categories Cancer

Developing nations likely to report two-third cancer cases by 2025, says UICC

Developing nations likely to report two-third cancer cases by 2025, says UICC PANAJI: Geneva-based organisation Union International for Cancer Control (UICC) on Thursday said that by 2025, two-third of the cancer cases in the world will come from the developing countries. UICC president Anil D’Cruz said this while addressing a gathering organised on the occasion […]

Read More